Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the impact of increasing levothyroxine dose during Ramadan in UAE patients with hypothyroidism has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Emirates Health Services (EHS) | Conditions: L-thyroxine | Phase 4 | Status: COMPLETED